Reflux esophagitis
Conditions
Interventions
We let reflux esophagitis patients take esomeprazole 20mg/day for 8 weeks
Sponsors
Oita university, department of Gastroenterology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patients who diagnosed as reflux esophagitis, Los Angeles classification, grade A, B, C, or D, by esophagogastroduodenoscopy
Exclusion criteria
Exclusion criteria: 1. Patients with active gastric ulcer or duodenal ulcer. 2. Patients with hypersensitivity to esomeprazole. 3. Patients in the administration of atazanavir sulfate or a Rirupibirin hydrochloride. 4. Patients with chronic alcoholism or drug dependence. 5. Patients with warning symptoms, such as vomitting, or sudden weight loss. 6. The patient who has difficulty in participation in this examination by the mergers such as a serious liver disease, renal disease, or heart trouble. 7. Pregnant women, nursing girls or the women who may be pregnant. 8. Patients who judged unsuitable for research participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The risk odds ratio of the low-dose aspirin for the reflux esophagitis onset | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate that reflux esophagitis improves by proton pump inhibitor administration | — |
Countries
Japan
Contacts
Public ContactKazuhiro Mizukami
Oita university Department of Gastroenterology
Outcome results
None listed